{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:43:48Z","timestamp":1792658628880,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["RO1 NS065829-01"],"award-info":[{"award-number":["RO1 NS065829-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ophtha.2019.09.012","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T18:36:50Z","timestamp":1569004610000},"page":"221-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Collapsin Response-Mediator Protein 5\u2013Associated Retinitis, Vitritis, and Optic Disc Edema"],"prefix":"10.1016","volume":"127","author":[{"given":"Devon A.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Tariq","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose S.","family":"Pulido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanda A.","family":"Lennon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divyanshu","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin P.","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"Pittock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ophtha.2019.09.012_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.ophtha.2019.09.012_bib2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E","article-title":"CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity","volume":"49","author":"Yu","year":"2001","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.ophtha.2019.09.012_bib3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.10178","article-title":"Paraneoplastic chorea associated with CRMP-5 neuronal antibody and lung carcinoma","volume":"51","author":"Vernino","year":"2002","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.ophtha.2019.09.012_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/ana.21324","article-title":"Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G","volume":"63","author":"Keegan","year":"2008","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ophtha.2019.09.012_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.10587","article-title":"Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG","volume":"54","author":"Cross","year":"2003","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.ophtha.2019.09.012_bib6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/0002-9394(76)90125-2","article-title":"Blindness caused by photoreceptor degeneration as a remote effect of cancer","volume":"81","author":"Sawyer","year":"1976","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ophtha.2019.09.012_bib7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archneur.55.3.405","article-title":"Paraneoplastic cerebellar syndrome and optic neuritis with anti-CV2 antibodies: clinical response to excision of the primary tumor","volume":"55","author":"De la Sayette","year":"1998","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.ophtha.2019.09.012_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1385\/CRIAI:19:1:51","article-title":"Anti-CV2 autoantibodies and paraneoplastic neurological syndromes","volume":"19","author":"Rogemond","year":"2000","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"10.1016\/j.ophtha.2019.09.012_bib9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00041327-200109000-00002","article-title":"Paraneoplastic optic neuropathy and cerebellar ataxia with small cell carcinoma of the lung","volume":"21","author":"Thambisetty","year":"2001","journal-title":"J\u00a0Neuroophthalmol"},{"issue":"9","key":"10.1016\/j.ophtha.2019.09.012_bib10","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/sj.eye.6702959","article-title":"Bilateral autoimmune optic neuritis and vitreitis related to CRMP-5-IgG: intravitreal triamcinolone acetonide therapy of four eyes","volume":"22","author":"Pulido","year":"2008","journal-title":"Eye"},{"issue":"1","key":"10.1016\/j.ophtha.2019.09.012_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00019052-200402000-00003","article-title":"Neuro-ophthalmology and paraneoplastic syndromes","volume":"17","author":"Bataller","year":"2004","journal-title":"Curr Opin Neurol"},{"issue":"2","key":"10.1016\/j.ophtha.2019.09.012_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.survophthal.2009.03.008","article-title":"Glazed (vision) and confused","volume":"55","author":"Moss","year":"2010","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"10.1016\/j.ophtha.2019.09.012_bib13","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.20269","article-title":"Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome","volume":"56","author":"Pittock","year":"2004","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.ophtha.2019.09.012_bib14","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.ophtha.2005.01.036","article-title":"Poor prognosis of visual outcome after visual loss from giant cell arteritis","volume":"112","author":"Danesh-Meyer","year":"2005","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ophtha.2019.09.012_bib15","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1212\/WNL.0000000000004803","article-title":"Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases","volume":"90","author":"Dubey","year":"2018","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ophtha.2019.09.012_bib16","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/WNL.50.3.652","article-title":"Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies","volume":"50","author":"Lucchinetti","year":"1998","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ophtha.2019.09.012_bib17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/1531-8249(20010201)49:2<214::AID-ANA41>3.0.CO;2-W","article-title":"Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy","volume":"49","author":"Antoine","year":"2001","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.ophtha.2019.09.012_bib18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ana.24872","article-title":"Microtubule-associated protein 1B: novel paraneoplastic biomarker","volume":"81","author":"Gadoth","year":"2017","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.ophtha.2019.09.012_bib19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/1531-8249(200003)47:3<297::AID-ANA4>3.0.CO;2-4","article-title":"New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity","volume":"47","author":"Vernino","year":"2000","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ophtha.2019.09.012_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/mus.25565","article-title":"GAD65 neurological autoimmunity","volume":"56","author":"McKeon","year":"2017","journal-title":"Muscle Nerve"},{"issue":"8","key":"10.1016\/j.ophtha.2019.09.012_bib21","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jamaneurol.2015.0749","article-title":"Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies","volume":"72","author":"Arino","year":"2015","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.ophtha.2019.09.012_bib22","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/1759-7714.13009","article-title":"Paraneoplastic autoimmunity and small-cell lung cancer: neurological and serological accompaniments","volume":"10","author":"Zekeridou","year":"2019","journal-title":"Thoracic Cancer"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642019320585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642019320585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:07:43Z","timestamp":1758982063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642019320585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0161642019320585"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.09.012","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Collapsin Response-Mediator Protein 5\u2013Associated Retinitis, Vitritis, and Optic Disc Edema","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2019.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}